Hogy Medical Co Ltd (HGYMF)
OTHER OTC:HGYMF
HGYMF Stock Chart & Stats
$42.82
$0.00(0.00%)
At close: 4:00 PM EDT
$42.82
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$22.57 - $46.31
Previous CloseN/A
Volume3.00
Average Volume (3M)40.00
Market Cap
$887.52M
Enterprise Value$137.47B
Total Cash (Recent Filing)$18.28B
Total Debt (Recent Filing)$12.17B
Price to Earnings (P/E)483.7
Beta0.38
Next Earnings
Jul 15, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.05%
Share Statistics
EPS (TTM)13.77
Shares Outstanding3
10 Day Avg. Volume0
30 Day Avg. Volume40
Financial Highlights & Ratios
PEG Ratio-1.30
Price to Book (P/B)1.10
Price to Sales (P/S)2.09
P/FCF Ratio13.07
Enterprise Value/Market Cap154.90
Enterprise Value/Revenue3.63
Enterprise Value/Gross Profit11.25
Enterprise Value/Ebitda17.55
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.9
Revenue Forecast (FY)$242.77M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage provides financial flexibility for capex, working capital or downturns. A debt-to-equity around 0.17 means the company can fund operations without heavy interest burden, preserving credit capacity and lowering solvency risk over the medium term.
Recurring Consumable RevenueCore business of sterile single-use supplies creates stable, repeatable demand from hospitals. This recurring consumption anchors predictable revenue streams tied to procedure volumes and procurement cycles, supporting steady cash inflows over months to years.
Stable Gross MarginsConsistent gross margins near the low-30% range indicate durable unit economics in manufacturing and pricing power on core products. Even with operating pressure, stable gross margin supports potential margin recovery if SG&A or overhead are better managed.
Bears Say
Shrinking Net ProfitabilityA steep drop in net margin signals weakening earnings power and margin compression that could persist without structural cost or mix changes. Low profitability limits reinvestment capacity and raises sensitivity to demand shocks and input cost inflation.
Sharp Free Cash Flow DeclineA ~72% FCF decline and FCF conversion ~0.2x of net income reduce the firm's ability to fund growth, pay dividends, or delever. Persistent weak cash conversion would constrain strategic flexibility and raises funding risk for investments or cyclical downturns.
Top-line And EPS DeteriorationDeclining revenue and near-collapse in EPS reflect weakening demand or margin pressure and hurt scale economies. Continued top-line erosion undermines long-term profitability prospects and hinders ability to restore ROE and shareholder returns absent product or market shifts.
Hogy Medical Co News
HGYMF FAQ
What was Hogy Medical Co Ltd’s price range in the past 12 months?
Hogy Medical Co Ltd lowest stock price was $22.57 and its highest was $46.31 in the past 12 months.
What is Hogy Medical Co Ltd’s market cap?
Hogy Medical Co Ltd’s market cap is $887.52M.
When is Hogy Medical Co Ltd’s upcoming earnings report date?
Hogy Medical Co Ltd’s upcoming earnings report date is Jul 15, 2026 which is in 19 days.
How were Hogy Medical Co Ltd’s earnings last quarter?
Hogy Medical Co Ltd released its earnings results on Apr 15, 2026. The company reported -$0.327 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.327.
Is Hogy Medical Co Ltd overvalued?
According to Wall Street analysts Hogy Medical Co Ltd’s price is currently Overvalued.
Does Hogy Medical Co Ltd pay dividends?
Hogy Medical Co Ltd pays a Quarterly dividend of $0.167 which represents an annual dividend yield of 2.05%. See more information on Hogy Medical Co Ltd dividends here
What is Hogy Medical Co Ltd’s EPS estimate?
Hogy Medical Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hogy Medical Co Ltd have?
Hogy Medical Co Ltd has 3 shares outstanding.
What happened to Hogy Medical Co Ltd’s price movement after its last earnings report?
Hogy Medical Co Ltd reported an EPS of -$0.327 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.048%.
Which hedge fund is a major shareholder of Hogy Medical Co Ltd?
Currently, no hedge funds are holding shares in HGYMF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Hogy Medical Co Ltd
Hogy Medical Co.,Ltd., along with its associated companies, is dedicated to providing medical provisions to healthcare institutions throughout Japan. Their product portfolio encompasses all-inclusive surgical kit solutions designed for pre-operative, intra-operative, and post-operative stages. They also manufacture a variety of non-woven items, such as surgical gowns, personal protective equipment, patient attire, drapes, pre-packaged goods, covers for instrument tables, and wraps. A unique offering is Tigalyer, a specialized multi-layer fabric. For effective sterilization, the company produces hybrid Mekkin bags, including an ID-layered variant, along with autoclave forceps stand caps. Furthermore, Hogy Medical offers Mekkin cards and ethylene oxide gas cards, both crucial for verifying the sterilization process in autoclaves and using ethylene oxide gas, respectively, complemented by indicator tapes for autoclave sterilization. On the technology front, they provide an ME equipment operation management system and an automated system leveraging radio frequency identification (RFID) to manage controlled medications and hazardous substances. Another innovative product is Securea, a polyurethane sponge specifically engineered for endoscopic surgical procedures. Founded in Tokyo, Japan, in 1955, the company operated as Hogy Co., Ltd. until 1987, when it officially changed its name to Hogy Medical Co.,Ltd.
Technical Analysis
Ownership Overview
―
Insiders
3.85% Mutual Funds
― Other Institutional Investors
95.96% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---